| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1B1
|
aldehyde dehydrogenase 1 family, member B1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMELX
|
amelogenin, X-linked
|
|
ANAPC16
|
anaphase promoting complex subunit 16
|
|
ANGPT2
|
angiopoietin 2
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANO7
|
anoctamin 7
|
|
API5
|
apoptosis inhibitor 5
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOL6
|
apolipoprotein L, 6
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARFGEF3
|
ARFGEF family member 3
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASPA
|
aspartoacylase
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATP6V0A2
|
ATPase, H+ transporting, lysosomal V0 subunit a2
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATXN3
|
ataxin 3
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B3GALTL
|
beta 1,3-galactosyltransferase-like
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BGN
|
biglycan
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BPIFA2
|
BPI fold containing family A, member 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
C3
|
complement component 3
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALML6
|
calmodulin-like 6
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASC15
|
cancer susceptibility candidate 15 (non-protein coding)
|
|
CASR
|
calcium-sensing receptor
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CCDC80
|
coiled-coil domain containing 80
|
|
CCK
|
cholecystokinin
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD177
|
CD177 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD38
|
CD38 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDO1
|
cysteine dioxygenase type 1
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CLU
|
clusterin
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CPSF3L
|
cleavage and polyadenylation specific factor 3-like
|
|
CRBN
|
cereblon
|
|
CREBBP
|
CREB binding protein
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DFNA27
|
deafness, autosomal dominant 27
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DMD
|
dystrophin
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DOK4
|
docking protein 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSG2
|
desmoglein 2
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYNC2H1
|
dynein, cytoplasmic 2, heavy chain 1
|
|
DYSF
|
dysferlin
|
|
EDN1
|
endothelin 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENPP7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPO
|
erythropoietin
|
|
EPRS
|
glutamyl-prolyl-tRNA synthetase
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETFDH
|
electron-transferring-flavoprotein dehydrogenase
|
|
EXO1
|
exonuclease 1
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FBN1
|
fibrillin 1
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FECH
|
ferrochelatase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FERMT2
|
fermitin family member 2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHII
|
Hyperaldosteronism, familial, type II
|
|
FHIT
|
fragile histidine triad
|
|
FHOD1
|
formin homology 2 domain containing 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBPL
|
FK506 binding protein like
|
|
FKTN
|
fukutin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXP3
|
forkhead box P3
|
|
FRMD7
|
FERM domain containing 7
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FXN
|
frataxin
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAS7
|
growth arrest-specific 7
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HBB
|
hemoglobin, beta
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HGSNAT
|
heparan-alpha-glucosaminide N-acetyltransferase
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HP1BP3
|
heterochromatin protein 1, binding protein 3
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGAD1
|
immunoglobulin A (IgA) deficiency susceptibility 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL16
|
interleukin 16
|
|
IL18
|
interleukin 18
|
|
IL21
|
interleukin 21
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INTS9
|
integrator complex subunit 9
|
|
IQCB1
|
IQ motif containing B1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JMJD1C
|
jumonji domain containing 1C
|
|
JMJD6
|
jumonji domain containing 6
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCTD7
|
potassium channel tetramerization domain containing 7
|
|
KDR
|
kinase insert domain receptor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT12
|
keratin 12, type I
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LACRT
|
lacritin
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LIF
|
leukemia inhibitory factor
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMOD1
|
leiomodin 1 (smooth muscle)
|
|
LTB4R
|
leukotriene B4 receptor
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARK4
|
MAP/microtubule affinity-regulating kinase 4
|
|
MATN3
|
matrilin 3
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED25
|
mediator complex subunit 25
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEST
|
mesoderm specific transcript
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR126
|
microRNA 126
|
|
MIR130A
|
microRNA 130a
|
|
MIR133B
|
microRNA 133b
|
|
MIR135B
|
microRNA 135b
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR21
|
microRNA 21
|
|
MIR212
|
microRNA 212
|
|
MIR301A
|
microRNA 301a
|
|
MIR34B
|
microRNA 34b
|
|
MIR382
|
microRNA 382
|
|
MIR429
|
microRNA 429
|
|
MIR499A
|
microRNA 499a
|
|
MIR510
|
microRNA 510
|
|
MIR885
|
microRNA 885
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MMAA
|
methylmalonic aciduria (cobalamin deficiency) cblA type
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOV10
|
Mov10 RISC complex RNA helicase
|
|
MOXD1
|
monooxygenase, DBH-like 1
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT1F
|
metallothionein 1F
|
|
MT2A
|
metallothionein 2A
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NENF
|
neudesin neurotrophic factor
|
|
NF1
|
neurofibromin 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRG4
|
neuregulin 4
|
|
NUP160
|
nucleoporin 160kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
NXF5
|
nuclear RNA export factor 5
|
|
OCA2
|
oculocutaneous albinism II
|
|
OPN4
|
opsin 4
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORM1
|
orosomucoid 1
|
|
OXTR
|
oxytocin receptor
|
|
PANK2
|
pantothenate kinase 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER3
|
period circadian clock 3
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PGR
|
progesterone receptor
|
|
PHB2
|
prohibitin 2
|
|
PHF1
|
PHD finger protein 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1L2
|
polycystic kidney disease 1-like 2 (gene/pseudogene)
|
|
PKD1L3
|
polycystic kidney disease 1-like 3
|
|
PKP2
|
plakophilin 2
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLG
|
plasminogen
|
|
PLIN2
|
perilipin 2
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM9
|
PR domain containing 9
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PSEN1
|
presenilin 1
|
|
PSKH2
|
protein serine kinase H2
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RDX
|
radixin
|
|
RET
|
ret proto-oncogene
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHOC
|
ras homolog family member C
|
|
RNASEH1
|
ribonuclease H1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPS19
|
ribosomal protein S19
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SBK2
|
SH3 domain binding kinase family, member 2
|
|
SCAMP5
|
secretory carrier membrane protein 5
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SEBOX
|
SEBOX homeobox
|
|
SELE
|
selectin E
|
|
SEPT14
|
septin 14
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFTPA1
|
surfactant protein A1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3BGRL
|
SH3 domain binding glutamate-rich protein like
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHH
|
sonic hedgehog
|
|
SLC10A4
|
solute carrier family 10, member 4
|
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
|
SOCS5
|
suppressor of cytokine signaling 5
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP110
|
SP110 nuclear body protein
|
|
SP3
|
Sp3 transcription factor
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPAST
|
spastin
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPOP
|
speckle-type POZ protein
|
|
SRPX
|
sushi-repeat containing protein, X-linked
|
|
SRPX2
|
sushi-repeat containing protein, X-linked 2
|
|
SRXN1
|
sulfiredoxin 1
|
|
SSFA2
|
sperm specific antigen 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
|
SYNPO2
|
synaptopodin 2
|
|
TACR3
|
tachykinin receptor 3
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
|
|
TBX15
|
T-box 15
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TENM4
|
teneurin transmembrane protein 4
|
|
TF
|
transferrin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM2
|
transglutaminase 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TJP1
|
tight junction protein 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TMEM43
|
transmembrane protein 43
|
|
TMPO
|
thymopoietin
|
|
TMPRSS3
|
transmembrane protease, serine 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM3
|
tropomyosin 3
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TRIM26
|
tripartite motif containing 26
|
|
TRIM71
|
tripartite motif containing 71, E3 ubiquitin protein ligase
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTC9B
|
tetratricopeptide repeat domain 9B
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
ULK4
|
unc-51 like kinase 4
|
|
UQCC3
|
ubiquinol-cytochrome c reductase complex assembly factor 3
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VWF
|
von Willebrand factor
|
|
WAPAL
|
wings apart-like homolog (Drosophila)
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WT1
|
Wilms tumor 1
|
|
YIPF4
|
Yip1 domain family, member 4
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZNF469
|
zinc finger protein 469
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZRSR2
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
|
